A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

NCT05618808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

373

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: REGN9933
DRUG: Enoxaparin
DRUG: Apixiban

Sponsor

Regeneron Pharmaceuticals